Ischemic-type biliary lesions after liver transplantation: A retrospective analysis of risk factors and outcome

Clinical Laboratory

Volumn 59, Issue 7-8, 2013, Pages 747-755

  Maccagno, Giancarlo ^a   Heise, Michael ^a   Hoppe Lotichius, Maria ^a   Weyer, Veronika ^a   Conradi, Roland ^a   Hitzler, Walter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Graft survival; HLA antibodies; HLA C1 genotype; HLA C2 genotype; Non anastomotic biliary strictures

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; RHESUS D ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BILIARY TRACT TUMOR; CHILD PUGH SCORE; COHORT ANALYSIS; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GRAFT SURVIVAL; HUMAN; ISCHEMIC TYPE BILIARY LESION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; ORGAN DONOR; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BILIARY TRACT DISEASES; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84883207058     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120630     Document Type: Article

References (15)

1. Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg 2006;13:517-24. (Pubitemid 46766707)
2. Wojcicki M, Milkiewicz P, Silva M. Biliary Tract Complications after Liver Transplantation: A Review. Dig Surg 2008;25:245-57.
3. Koch RO, Kaser A. Genetic insights into non-anastomotic biliary strictures after orthotopic liver transplantation. Liver Int 2011;31:1065-7.
4. Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. 2010;23:14-22.
5. Moench C, Uhrig A, Lohse AW, Otto G, CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 2004;10:434-9. (Pubitemid 38380320)
6. op den Dries S, Buis CI, Adelmeijer J, et al. Combination of PSC and CCR5-D32 in recipients is strongly associated with development of nonanastomotic biliary strictures after liver transplantation. Liver Int 2011;31:1102-9.
7. Ten Hove WR, Korkmaz KS, op den Dries S, et al. Matrixmetalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int 2011;31:1110-7.
8. Sanchez-Urdazpal L, Bafts KP, Gores GJ, et al. Increased Bile Duct Complications in Liver Transplantation Across the ABO Barrier. Ann Surg 1993;218:152-8. (Pubitemid 23229141)
9. Busquets J, Castellote J, Torras J, et al. Liver transplantation across Rh blood group barriers increases the risk of biliary complications. J Gastrointest Surg 2007;11:458-63.
10. Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M. Prevalence of anti-HLA antibodies after liver transplantation [letter]. Transpl Int 2010;23:858-9.
11. Hanvesakul R, Spencer N, Cook M, et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008;8:1931-41.
12. Tran TH, Middleton D, Doehler B, et al. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant 2009;9:1674-8.
13. Moroso V, van der Meer A, Tilanus HW, et al. Donor and recipeent HLA/KIR genotypes do not predict liver transplantation outcome. Transpl Int 2011;24:932-42.
14. Faridi RM, Agrawal S. Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages. Hum Reprod 2011;26:491-7.
15. Heidenhain C, Puhl G, Moench C, Lautem A, Neuhaus P. Chemokine Receptor-5A32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation. J Transplant 2009;2009:436515.